Safety Concerns Prompt Parental Refusal of HPV Vaccine for Teens
Study highlights decreased confidence in the human papillomavirus vaccine in the United States.
Study highlights decreased confidence in the human papillomavirus vaccine in the United States.
Cutaneous beta-human papillomavirus (HPV) may predict development of cutaneous squamous cell carcinoma (cuSCC).
The researchers’ goal was to study the risk factors for multicentric intraepithelial lesions of the lower genital tract, including specific human papillomavirus genotypes.
Investigators evaluated the sustainability of neutralizing antibody and cross-neutralizing antibody concentrations following administration of the bivalent or quadrivalent human papillomavirus vaccine.
Researchers examined the efficacy and safety of the quadrivalent human papillomavirus vaccine for young men who have sex with men and are living with HIV.
At-home HPV self-sampling may be a viable option to increase cervical screening rates in rural, underserved women.
For HPV-related cancers without standardized screening, incidence rates increased between 2001 and 2017.
Investigators examined incidence, clearance, and risk factors for 13 high-risk human papilloma virus types in gay and bisexual men with HIV.
Study authors assessed the relationship between quadrivalent HPV vaccination and risk of invasive cervical cancer and age of vaccination.
Researchers conducted a prospective cohort study to assess rates of new HPV detection and loss of detection in middle-age women.